Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice

European Journal of Endocrinology

Volumn 139, Issue 4, 1998, Pages 461-467

  Ahrén, Bo ^a,c   Scheurink, Anton J W ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LEPTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FAT INTAKE; FATTY ACID BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALS; BODY WEIGHT; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LEPTIN; MICE; MICE, INBRED C57BL; PROTEINS;

EID: 0031786715     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1390461     Document Type: Article

References (36)

1. Olefsky JM, Kolterman OG & Scarlet JA. Insulin action and resistance in obesity and non-insulin dependent type II diabetes mellitus. American Journal of Physiology 1982 243 E15-E30.
2. Larsson H & Ahrén B. Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 1995 45 502-509.
3. Unger R. How obesity causes diabetes in Zucker diabetic fatty rats. Trends in Endocrinology and Metabolism 1998 7 276-282.
4. Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes and Metabolism 1996 22 122-131.
5. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes 1982 31 1-6.
6. Ahrén B, Simonsson E, Scheurink AJW, Mulder H, Myrsén U & Sundler F. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 1997 46 97-106.
7. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA & Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988 37 1163-1167.
8. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995 44 645-651.
9. Lee SK, Opara EC, Surwit RS, Feinglos MN & Akwari OE. Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas 1995 11 206-211.
10. Ahrén B, Månsson S, Gingerich RL & Havel PJ. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. American Journal of Physiology 1997 273 R113-R120.
11. Surwit RS, Petro AE, Parekh P & Vollins S. Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice. Diabetes 1997 46 1516-1520.
12. Antonis A. Semiautomated method for the colorimetric determination of plasma free fatty acids. Journal of Lipid Research 1965 6 307-312.
13. Duncan MH, Singh BM, Wise PH, Carter G & Allagband-Zadeh J. A simple measure of insulin resistance. Lancet 1995 346 120-121.
14. Bastard JP, Grimaldi A, Jardel C, Porquet D, Bruckert E & Hainque B. A simple index of insulin resistance. Diabetes and Metabolism 1997 23 87-88.
15. Koyama K, Chen G, Lee Y & Unger RH. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. American Journal of Physiology 1997 273 E708-E713.
16. Kraegen EW, James DE, Storlien LH, Burleigh KM & Chisholm DJ. In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycemic clamp plus deoxyglucose administration. Diabetologia 1986 29 192-198.
17. Storlien LH, James DE, Burleigh KM, Chisholm DJ & Kraegen EW. Fat feeding causes widespread insulin resistance, decreased energy expenditure and obesity in rats. American Journal of Physiology 1986 251 E576-E583.
18. Larsson H, Elmståhl S & Ahrén B. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 1996 45 1581-1584.
19. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL & Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. Journal of Clinical Endocrinology and Metabolism 1996 81 4406-4413.
20. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F & Jeanrenaud B. Intracerebral administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia 1996 39 353-356.
21. Ahrén B & Larsson H. Leptin - a regulator of islet function? Its plasma levels correlate with glucagon and insulin secretion in healthy women. Metabolism 1997 46 1477-1481.
22. Tanizawa Y, Okuya S, Ishihara H, Asabo T, Yada T & Oka Y. Direct stimulation of basal insulin secretion by physiological concentrations of leptin in pancreatic beta cells. Endocrinology 1997 138 4513-4516.
23. Shimizu H, Ohtani KI, Tsuchia T, Takahashi H, Uehara Y, Sato N et al. Leptin stimulates insulin secretion and synthesis in HIT-T 15 cells. Peptides 1997 18 1263-1266.
24. Pallett AL, Morton NM, Cawthorne MA & Emilsson V. Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets. Biochemical and Biophysical Research Communications 1997 238 267-270.
25. Chen NG, Swick AG & Romsos DR. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice. Journal of Clinical Investigation 1997 100 1174-1179.
26. + channels in pancreatic islets. Diabetes 1997 46 1087-1093.
27. Trupeinen AK, Haffner SM, Louheranta AM, Niskanen LK, Miettinen H & Uusitupa MI. Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin response. International Journal of Obesity and Related Metabolic Disorders 1997 21 284-287.
28. Haffner SM, Miettinen H, Mykkanen L, Karhapaa P, Rainwater DL & Laakso M. Leptin concentrations and insulin sensitivity in normoglycemic men. International Journal of Obesity and Related Metabolic Disorders 1997 21 393-399.
29. Paolisso G, Tacunni FA, Foley JA, Bogardus C, Howard BV & Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995 38 1213-1217.
30. Greenough WB, Crespin SR & Steinberg D. Hypoglycemia and hyperinsulinemia in response to raised free fatty acid levels. Lancet 1967 2 1334-1336.
31. Hennes MMI, Dua A, Maas DL, Sonnenberg GE, Krakower GR & Kissebah AH. Relationships of plasma leptin levels to changes in plasma free fatty acids in women who are lean and women who are abdominally obese. Obesity Research 1997 5 442-446.
32. Ferrannini E, Barrett EJ, Bovilacqua S & DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. Journal of Clinical Investigation 1983 72 1737-1747.
33. McGarry JD. Disordered metabolism in diabetes: have we under-emphasized the fat cell component? Journal of Cellular Biochemistry 1994 565 29-38.
34. Cohen B, Novick D & Rubinstein M. Modulation of insulin activities by leptin. Science 1996 274 1185-1188.
35. Muller G, Ertl J, Gerl M & Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. Journal of Biological Chemistry 1997 272 10585-10593.
36. Barzilai N, Wang JL, Massilon D, Vuguin P, Hawkins M & Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. Journal of Clinical Investigation 1997 100 3105-3110.